Open Access
REVIEW
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations
* Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, P.R. China
† Department of Oncology, Dalian Fifth People’s Hospital, Dalian, P.R. China